| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |